Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Troels Mygind Jensen

Troels Mygind Jensen


Niels Steensens Vej 2-4

Bygning: NSH

2820 Gentofte


Vis graf over relationer


Biomarkers for type 2 diabetes and complications - investigation of biological markers to describe and predict the progression of prediabetes to type 2 diabetes and associated complications.

Aktuel forskning

I am currently attached to the RHAPSODY project in a post-doc position: The RHAPSODY consortium aims at identifying, characterizing and validating biomarkers for onset of diabetes / diabetes progression in order to enable disease modification.  By combining clinical and genetic data from several European cohorts, changes in glucose metabolism before and after diabetes onset will be assessed in order to establish biomarkers of glucose dysregulation potential involvement of genetic factors. RHAPSODY involves several academic and industrial partners, where SDCC works particularly with the Lund University Diabetes Centre, (Malmö, Sweden), the Swiss Institute of Bioinformatics (Lausanne, Switzerland) and Novo Nordisk (Måløv, Denmark).

ID: 50238325